ACACIA RESEARCH CORPORATION (NASDAQ:ACTG) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07.Submission of Matters to a Vote of Security Holders.

On June 14, 2018, Acacia Research Corporation (“Acacia” or the “Company”) held its 2018 annual meeting of stockholders (the “Annual Meeting”). The Annual Meeting was held at 660 Newport Center Drive, Suite 1600, Newport Beach, California. As of May 10, 2018, the record date for the Annual Meeting, there were 51,247,882 shares of common stock of the Company issued and outstanding and entitled to vote. At the Annual Meeting, 41,368,945 shares of the Company’s common stock were present in person or represented by proxy and entitled to vote, constituting a quorum for the conduct of business at the Annual Meeting.

Set forth below are the proposals voted upon at the Annual Meeting, and the final results of the stockholder vote on each proposal, as certified by First Coast Results, Inc., the inspector of election for the Annual Meeting.

Proposal No. 1: To elect two Class III directors to serve on the Board of Directors for a term of three years expiring upon the 2021 Annual Meeting of Stockholders or until their successors are duly elected and qualified.

Board of Director Nominees:

Sidus Investment Management, LLC and BLR Partners LP Nominees:

Proposal No. 2: To ratify the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018.

Proposal No. 3: To approve, by advisory vote, the compensation of the Company’s named executive officers detailed in the proxy statement for the Annual Meeting.

Proposal No. 4: To approve the adoption of the 2018 Acacia Research Corporation Stock Incentive Plan, which authorizes the issuance of equity awards, including stock options, restricted stock units and direct stock awards.

About ACACIA RESEARCH CORPORATION (NASDAQ:ACTG)

Acacia Research Corporation, through its subsidiaries, is engaged in patent investment, prosecution, licensing and enforcement activities. The Company’s subsidiaries partner with inventors and patent owners for patented inventions. The Company operates in patent licensing and enforcement business segment. The Company’s subsidiaries generate revenues from the granting of intellectual property rights for the use of patented technologies that its subsidiaries control or own. The Company’s subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation. It is engaged in licensing and enforcing patented technologies. Its subsidiaries include Adaptix, Inc. and Body Science, LLC.